Companies / Clovis Oncology, Inc.
Clovis Oncology, Inc.
CLVSCIK 1466301
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 5, 2015 | Blair James C Director | Sell Open-market sale | Common Stock | $662.6K | -9K -19.37% | 35,506 | medium |
| Mar 9, 2015 | Mast Erle T Executive | Sell Open-market sale | Common Stock | $661.7K | -8K -4.98% | 160,183 | medium |
| Feb 2, 2021 | Rolfe Lindsey Executive | Sell Open-market sale | Common Stock | $78.3K | -10K -12.51% | 68,712 | low |
| Feb 2, 2021 | Gross Paul Edward Executive | Sell Open-market sale | Common Stock | $73.8K | -9K -17.73% | 42,945 | low |
| Feb 2, 2021 | Muehl Daniel W Executive | Sell Open-market sale | Common Stock | $73.8K | -9K -16.45% | 46,990 | low |
| Feb 2, 2021 | Ivers-Read Gillian C Executive | Sell Open-market sale | Common Stock | $72.0K | -9K -3.56% | 244,346 | low |
| Mar 12, 2021 | Harding Thomas C. Executive | Sell Open-market sale | Common Stock | $44.1K | -7K -100.00% | 0 | low |
| Mar 9, 2015 | Mast Erle T Executive | Sell Open-market sale | Common Stock | $39.8K | -500 -0.31% | 159,683 | low |